Operating Lease, Right-of-Use Asset of Niagen Bioscience, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Niagen Bioscience, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Niagen Bioscience, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,361,000, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Niagen Bioscience, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,361,000 +$462,000 +24% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $2,525,000 +$462,000 +22% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $2,684,000 +$458,000 +21% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $1,730,000 -$670,000 -28% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $1,899,000 -$1,104,000 -37% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $2,063,000 -$1,116,000 -35% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $2,226,000 -$1,126,000 -34% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $2,400,000 -$1,123,000 -32% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $3,003,000 -$711,000 -19% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $3,179,000 -$705,000 -18% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $3,352,000 -$701,000 -17% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $3,523,000 -$829,000 -19% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 $3,714,000 +$665,000 +22% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $3,884,000 +$702,000 +22% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $4,053,000 +$2,953,000 +268% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $4,352,000 +$3,126,000 +255% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 $3,049,000 +$1,726,000 +130% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $3,182,000 +$2,477,000 +351% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $1,100,000 +$301,000 +38% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $1,226,000 +$335,000 +38% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q3 2020 $1,323,000 +$278,000 +27% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $705,000 -$485,000 -41% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $799,000 -$501,000 -39% 31 Mar 2020 10-Q 18 May 2020 2020 Q1
Q4 2019 $891,000 +$891,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $1,045,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,190,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $1,300,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 10 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.